UC Collaborative to Reduce Hospital Acquired Venous thromboembolism(HA VTE); Stop the Clot

Sponsor: University of California San Diego (UCSD)

Location(s): United States


Pulmonary embolism (PE) and deep vein thrombosis (DVT), collectively referred to as venous thromboembolism (VTE), affects 350,000 – 900,000 Americans each year. Almost 1000 UC patients per year suffer from hospital- associated VTE (HA VTE).   While some UC sites had earlier success, UC faced many challenges in providing optimal DVT prophylaxis.   We set out to address these barriers, maximize the quality of VTE prophylaxis delivery across the UC system, and target a reduction in the incidence of HA VTE at UC hospitals by at least 20%. 

Aim 1: Build a UC wide QI collaborative infrastructure for improving VTE prophylaxis, portable to a range of future QI and research project.

Aim2: Measure the quality of VTE prophylaxis and track the incidence of HA VTE.

Aim3: Intervene to improve the quality of VTEP.

Aim 4: Cooperatively collect data defining risk factors for HA VTE and providing a focus for future research and QI efforts.